Global Direct-to-Consumer Laboratory Testing

Direct-to-Consumer Laboratory Testing Comprehensive Study by Type (Blood, Urine, Saliva, Others), Application (Adult, Children), (), End-use (Hospitals, Clinics, Specialty labs,, Diagnostic centers.) Players and Region - Global Market Outlook to 2028

Direct-to-Consumer Laboratory Testing Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Direct-to-Consumer Laboratory Testing Market Scope
Direct-to-consumer (DTC) laboratory testing is known as direct access testing that enables patients to order tests directly from the laboratory without physical visiting to a healthcare practitioner. Direct-To-Consumer consists of advanced technology tests which can be used to track a current health condition, diagnose a previously undiagnosed medical issue, or provide information on personal health traits. DTC laboratory testing plays an important for customer engagement in their healthcare with accurate and accessible testing samples. Due to the increased hetic lifestyle which is associated and infectious diseases such as obesity, hypertension, diabetes, cancer, and STD has increased. Geographically, North America is the leading region for higher adoption for direct-to-customer laboratory testing due to an increase in heart disease and cancer which is triggering for higher adoption direct to customer laboratory testing. The demand for direct-to-customer laboratory testing is driving the growth of the market over the forecast period.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledEverlyWell, Inc (United States), Laboratory Corporation of America Holding (United States), DirectLabs, LLC (United States), MyMedLab, Inc (United States), WellnessFX (United States), ANY LAB TEST NOW (United States), LetsGetChecked (Ireland), Color Health (United States), 23andMe, Inc (United States), Sonora Quest (United States) and Ancestry.com LLC (United States)
CAGR%


The market is expected to grow market in hospitals. It has wide application various clinical programs and seminars is driving the demand for the market. Several companies such as EverlyWell, Inc, Laboratory Corporation of America Holding, DirectLabs, LLC are operating in the market to provide customers with better offers with various features & unique offerings. The market is a partially fragmented market with the presence of several market players and local players. Which is triggering the market growth over the forecast perio Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Direct-to-Consumer Laboratory Testing market throughout the predicted period.

EverlyWell, Inc (United States), Laboratory Corporation of America Holding (United States), DirectLabs, LLC (United States), MyMedLab, Inc (United States), WellnessFX (United States), ANY LAB TEST NOW (United States), LetsGetChecked (Ireland), Color Health (United States), 23andMe, Inc (United States), Sonora Quest (United States) and Ancestry.com LLC (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Quest Diagnostic Incorporated (United States), Myriad Genetics (United States) and Others.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Direct-to-Consumer Laboratory Testing market by Type , by Application (Adult and Children) and Region with country level break-up.

On the basis of geography, the market of Direct-to-Consumer Laboratory Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
On July 2021 Genetic technologies had acquired DTC Genetic Test Provider for EasyDNA.The acquisition cost is USD 4M., and In June 2021 Eurofins has acquired a DNA diagnostics Centre to grow genetic testing Capabilities and significantly into the Consumer Testing Market
On November 2021, Cue Health has launched a Direct-To-Consumer virtual health platform kind to test available to people across the United States through Cue's new e-commerce site and app shop


Influencing Trend:
Laboratory Information and Management Systems (LIMS) are currently the solution to data management in modern laboratories for data tracking

Market Growth Drivers:
It is easy to order and It is easily Access able from remote locations at any time and any location

Challenges:
Negative testing may increase your stress and anxiety.

Restraints:
It is easy to order and It is easily Access able from remote locations at any time and any location

Opportunities:
Rising demand with advances in technology such machine learning for faster testing result

Key Target Audience
OEM (Original Equipment Manufacturing), Supplier, Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Blood
  • Urine
  • Saliva
  • Others
By Application
  • Adult
  • Children
By End-use
  • Hospitals
  • Clinics
  • Specialty labs,
  • Diagnostic centers.

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. It is easy to order
      • 3.2.2. It is easily Access able from remote locations at any time and any location
    • 3.3. Market Challenges
      • 3.3.1. Negative testing may increase your stress and anxiety.
    • 3.4. Market Trends
      • 3.4.1. Laboratory Information and Management Systems (LIMS) are currently the solution to data management in modern laboratories for data tracking
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Direct-to-Consumer Laboratory Testing, by Type, Application, , End-use and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Direct-to-Consumer Laboratory Testing (Value)
      • 5.2.1. Global Direct-to-Consumer Laboratory Testing by: Type (Value)
        • 5.2.1.1. Blood
        • 5.2.1.2. Urine
        • 5.2.1.3. Saliva
        • 5.2.1.4. Others
      • 5.2.2. Global Direct-to-Consumer Laboratory Testing by: Application (Value)
        • 5.2.2.1. Adult
        • 5.2.2.2. Children
      • 5.2.3. Global Direct-to-Consumer Laboratory Testing by: End-use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Specialty labs,
        • 5.2.3.4. Diagnostic centers.
      • 5.2.4. Global Direct-to-Consumer Laboratory Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Direct-to-Consumer Laboratory Testing (Price)
      • 5.3.1. Global Direct-to-Consumer Laboratory Testing by: Type (Price)
  • 6. Direct-to-Consumer Laboratory Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. EverlyWell, Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Laboratory Corporation of America Holding (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. DirectLabs, LLC (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MyMedLab, Inc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. WellnessFX (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ANY LAB TEST NOW (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LetsGetChecked (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Color Health (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. 23andMe, Inc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sonora Quest (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Ancestry.com LLC (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Direct-to-Consumer Laboratory Testing Sale, by Type, Application, , End-use and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Direct-to-Consumer Laboratory Testing (Value)
      • 7.2.1. Global Direct-to-Consumer Laboratory Testing by: Type (Value)
        • 7.2.1.1. Blood
        • 7.2.1.2. Urine
        • 7.2.1.3. Saliva
        • 7.2.1.4. Others
      • 7.2.2. Global Direct-to-Consumer Laboratory Testing by: Application (Value)
        • 7.2.2.1. Adult
        • 7.2.2.2. Children
      • 7.2.3. Global Direct-to-Consumer Laboratory Testing by: End-use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Specialty labs,
        • 7.2.3.4. Diagnostic centers.
      • 7.2.4. Global Direct-to-Consumer Laboratory Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Direct-to-Consumer Laboratory Testing (Price)
      • 7.3.1. Global Direct-to-Consumer Laboratory Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Direct-to-Consumer Laboratory Testing: by Type(USD Million)
  • Table 2. Direct-to-Consumer Laboratory Testing Blood , by Region USD Million (2017-2022)
  • Table 3. Direct-to-Consumer Laboratory Testing Urine , by Region USD Million (2017-2022)
  • Table 4. Direct-to-Consumer Laboratory Testing Saliva , by Region USD Million (2017-2022)
  • Table 5. Direct-to-Consumer Laboratory Testing Others , by Region USD Million (2017-2022)
  • Table 6. Direct-to-Consumer Laboratory Testing: by Application(USD Million)
  • Table 7. Direct-to-Consumer Laboratory Testing Adult , by Region USD Million (2017-2022)
  • Table 8. Direct-to-Consumer Laboratory Testing Children , by Region USD Million (2017-2022)
  • Table 9. Direct-to-Consumer Laboratory Testing: by End-use(USD Million)
  • Table 10. Direct-to-Consumer Laboratory Testing Hospitals , by Region USD Million (2017-2022)
  • Table 11. Direct-to-Consumer Laboratory Testing Clinics , by Region USD Million (2017-2022)
  • Table 12. Direct-to-Consumer Laboratory Testing Specialty labs, , by Region USD Million (2017-2022)
  • Table 13. Direct-to-Consumer Laboratory Testing Diagnostic centers. , by Region USD Million (2017-2022)
  • Table 14. South America Direct-to-Consumer Laboratory Testing, by Country USD Million (2017-2022)
  • Table 15. South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 16. South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 17. South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 18. Brazil Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 19. Brazil Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 20. Brazil Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 21. Argentina Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 22. Argentina Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 23. Argentina Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 24. Rest of South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 25. Rest of South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 26. Rest of South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 27. Asia Pacific Direct-to-Consumer Laboratory Testing, by Country USD Million (2017-2022)
  • Table 28. Asia Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 29. Asia Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 30. Asia Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 31. China Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 32. China Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 33. China Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 34. Japan Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 35. Japan Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 36. Japan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 37. India Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 38. India Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 39. India Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 40. South Korea Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 41. South Korea Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 42. South Korea Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 43. Taiwan Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 44. Taiwan Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 45. Taiwan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 46. Australia Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 47. Australia Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 48. Australia Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 52. Europe Direct-to-Consumer Laboratory Testing, by Country USD Million (2017-2022)
  • Table 53. Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 54. Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 55. Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 56. Germany Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 57. Germany Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 58. Germany Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 59. France Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 60. France Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 61. France Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 62. Italy Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 63. Italy Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 64. Italy Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 65. United Kingdom Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 66. United Kingdom Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 67. United Kingdom Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 68. Netherlands Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 69. Netherlands Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 70. Netherlands Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 71. Rest of Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 72. Rest of Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 73. Rest of Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 74. MEA Direct-to-Consumer Laboratory Testing, by Country USD Million (2017-2022)
  • Table 75. MEA Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 76. MEA Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 77. MEA Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 78. Middle East Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 79. Middle East Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 80. Middle East Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 81. Africa Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 82. Africa Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 83. Africa Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 84. North America Direct-to-Consumer Laboratory Testing, by Country USD Million (2017-2022)
  • Table 85. North America Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 86. North America Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 87. North America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 88. United States Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 89. United States Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 90. United States Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 91. Canada Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 92. Canada Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 93. Canada Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 94. Mexico Direct-to-Consumer Laboratory Testing, by Type USD Million (2017-2022)
  • Table 95. Mexico Direct-to-Consumer Laboratory Testing, by Application USD Million (2017-2022)
  • Table 96. Mexico Direct-to-Consumer Laboratory Testing, by End-use USD Million (2017-2022)
  • Table 97. Direct-to-Consumer Laboratory Testing: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Direct-to-Consumer Laboratory Testing: by Type(USD Million)
  • Table 110. Direct-to-Consumer Laboratory Testing Blood , by Region USD Million (2023-2028)
  • Table 111. Direct-to-Consumer Laboratory Testing Urine , by Region USD Million (2023-2028)
  • Table 112. Direct-to-Consumer Laboratory Testing Saliva , by Region USD Million (2023-2028)
  • Table 113. Direct-to-Consumer Laboratory Testing Others , by Region USD Million (2023-2028)
  • Table 114. Direct-to-Consumer Laboratory Testing: by Application(USD Million)
  • Table 115. Direct-to-Consumer Laboratory Testing Adult , by Region USD Million (2023-2028)
  • Table 116. Direct-to-Consumer Laboratory Testing Children , by Region USD Million (2023-2028)
  • Table 117. Direct-to-Consumer Laboratory Testing: by End-use(USD Million)
  • Table 118. Direct-to-Consumer Laboratory Testing Hospitals , by Region USD Million (2023-2028)
  • Table 119. Direct-to-Consumer Laboratory Testing Clinics , by Region USD Million (2023-2028)
  • Table 120. Direct-to-Consumer Laboratory Testing Specialty labs, , by Region USD Million (2023-2028)
  • Table 121. Direct-to-Consumer Laboratory Testing Diagnostic centers. , by Region USD Million (2023-2028)
  • Table 122. South America Direct-to-Consumer Laboratory Testing, by Country USD Million (2023-2028)
  • Table 123. South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 124. South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 125. South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 126. Brazil Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 127. Brazil Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 128. Brazil Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 129. Argentina Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 130. Argentina Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 131. Argentina Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 132. Rest of South America Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 133. Rest of South America Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 134. Rest of South America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 135. Asia Pacific Direct-to-Consumer Laboratory Testing, by Country USD Million (2023-2028)
  • Table 136. Asia Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 137. Asia Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 138. Asia Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 139. China Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 140. China Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 141. China Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 142. Japan Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 143. Japan Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 144. Japan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 145. India Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 146. India Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 147. India Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 148. South Korea Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 149. South Korea Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 150. South Korea Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 151. Taiwan Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 152. Taiwan Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 153. Taiwan Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 154. Australia Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 155. Australia Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 156. Australia Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 160. Europe Direct-to-Consumer Laboratory Testing, by Country USD Million (2023-2028)
  • Table 161. Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 162. Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 163. Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 164. Germany Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 165. Germany Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 166. Germany Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 167. France Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 168. France Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 169. France Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 170. Italy Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 171. Italy Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 172. Italy Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 173. United Kingdom Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 174. United Kingdom Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 175. United Kingdom Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 176. Netherlands Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 177. Netherlands Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 178. Netherlands Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 179. Rest of Europe Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 180. Rest of Europe Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 181. Rest of Europe Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 182. MEA Direct-to-Consumer Laboratory Testing, by Country USD Million (2023-2028)
  • Table 183. MEA Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 184. MEA Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 185. MEA Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 186. Middle East Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 187. Middle East Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 188. Middle East Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 189. Africa Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 190. Africa Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 191. Africa Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 192. North America Direct-to-Consumer Laboratory Testing, by Country USD Million (2023-2028)
  • Table 193. North America Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 194. North America Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 195. North America Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 196. United States Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 197. United States Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 198. United States Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 199. Canada Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 200. Canada Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 201. Canada Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 202. Mexico Direct-to-Consumer Laboratory Testing, by Type USD Million (2023-2028)
  • Table 203. Mexico Direct-to-Consumer Laboratory Testing, by Application USD Million (2023-2028)
  • Table 204. Mexico Direct-to-Consumer Laboratory Testing, by End-use USD Million (2023-2028)
  • Table 205. Direct-to-Consumer Laboratory Testing: by Type(USD/Units)
  • Table 206. Research Programs/Design for This Report
  • Table 207. Key Data Information from Secondary Sources
  • Table 208. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Direct-to-Consumer Laboratory Testing: by Type USD Million (2017-2022)
  • Figure 5. Global Direct-to-Consumer Laboratory Testing: by Application USD Million (2017-2022)
  • Figure 6. Global Direct-to-Consumer Laboratory Testing: by End-use USD Million (2017-2022)
  • Figure 7. South America Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 8. Asia Pacific Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 9. Europe Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 10. MEA Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 11. North America Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 12. Global Direct-to-Consumer Laboratory Testing: by Type USD/Units (2017-2022)
  • Figure 13. Global Direct-to-Consumer Laboratory Testing share by Players 2022 (%)
  • Figure 14. Global Direct-to-Consumer Laboratory Testing share by Players (Top 3) 2022(%)
  • Figure 15. Global Direct-to-Consumer Laboratory Testing share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. EverlyWell, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 18. EverlyWell, Inc (United States) Revenue: by Geography 2022
  • Figure 19. Laboratory Corporation of America Holding (United States) Revenue, Net Income and Gross profit
  • Figure 20. Laboratory Corporation of America Holding (United States) Revenue: by Geography 2022
  • Figure 21. DirectLabs, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 22. DirectLabs, LLC (United States) Revenue: by Geography 2022
  • Figure 23. MyMedLab, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 24. MyMedLab, Inc (United States) Revenue: by Geography 2022
  • Figure 25. WellnessFX (United States) Revenue, Net Income and Gross profit
  • Figure 26. WellnessFX (United States) Revenue: by Geography 2022
  • Figure 27. ANY LAB TEST NOW (United States) Revenue, Net Income and Gross profit
  • Figure 28. ANY LAB TEST NOW (United States) Revenue: by Geography 2022
  • Figure 29. LetsGetChecked (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. LetsGetChecked (Ireland) Revenue: by Geography 2022
  • Figure 31. Color Health (United States) Revenue, Net Income and Gross profit
  • Figure 32. Color Health (United States) Revenue: by Geography 2022
  • Figure 33. 23andMe, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 34. 23andMe, Inc (United States) Revenue: by Geography 2022
  • Figure 35. Sonora Quest (United States) Revenue, Net Income and Gross profit
  • Figure 36. Sonora Quest (United States) Revenue: by Geography 2022
  • Figure 37. Ancestry.com LLC (United States) Revenue, Net Income and Gross profit
  • Figure 38. Ancestry.com LLC (United States) Revenue: by Geography 2022
  • Figure 39. Global Direct-to-Consumer Laboratory Testing: by Type USD Million (2023-2028)
  • Figure 40. Global Direct-to-Consumer Laboratory Testing: by Application USD Million (2023-2028)
  • Figure 41. Global Direct-to-Consumer Laboratory Testing: by End-use USD Million (2023-2028)
  • Figure 42. South America Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 43. Asia Pacific Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 44. Europe Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 45. MEA Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 46. North America Direct-to-Consumer Laboratory Testing Share (%), by Country
  • Figure 47. Global Direct-to-Consumer Laboratory Testing: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • EverlyWell, Inc (United States)
  • Laboratory Corporation of America Holding (United States)
  • DirectLabs, LLC (United States)
  • MyMedLab, Inc (United States)
  • WellnessFX (United States)
  • ANY LAB TEST NOW (United States)
  • LetsGetChecked (Ireland)
  • Color Health (United States)
  • 23andMe, Inc (United States)
  • Sonora Quest (United States)
  • Ancestry.com LLC (United States)
Additional players considered in the study are as follows:
Quest Diagnostic Incorporated (United States) , Myriad Genetics (United States) , Others
Select User Access Type

Key Highlights of Report


Dec 2023 214 Pages 63 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Direct-to-Consumer Laboratory Testing Quantitative research analysis
Global Direct-to-Consumer Laboratory Testing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Direct-to-Consumer Laboratory Testing Market are by type [Blood, Urine, Saliva and Others], by end use application [Adult and Children].
The Direct-to-Consumer Laboratory Testing Market is gaining popularity and expected to see strong valuation by 2028.
  • It is easy to order
  • It is easily Access able from remote locations at any time and any location

Know More About Global Direct-to-Consumer Laboratory Testing Report?

Have a Query? Click Here

Other Related Reports

Low Power Wide Area Network (LPWAN) Comprehensive Study by Type (Public Sector, Private Sector), Application (Smart Gas and Water Metering, Asset Tracking, Smart Agriculture, Smart Buildings, Smart L...
$ 3800
Crude Oil Flow Improvers (COFI) Comprehensive Study by Type (Paraffin Inhibitors, Asphaltene Inhibitors, Scale and Corrosion Inhibitors, Drag Reducing Agent, Others), Application (Extraction, Pipelin...
$ 3800
Camp Registration Software Comprehensive Study by Type (Cloud Based, On-Premises), Application (Camp Professionals, Schools, Others), Deployment Mode (Cloud Based, On-Premises), User (1-9, 10-50, 50-...
$ 3750
Ear Plugs (Earplug) Comprehensive Study by Type (In-ear, On-ear) Players and Region - Global Market Outlook to 2028
$ 3800
Flexible Office Comprehensive Study by End Users (SMEs, Large Enterprises), Organisation (Public, Private), Industry Verticals (IT & Telecommunications, Media & Entertainment, Retail & Consumer Goods...
$ 3450
Diaper Hobo Bag Comprehensive Study by Type (Leathery, Textile, Other), Application (Maternity & Childcare Store, Brand Store, Supermarket, Online, Other) Players and Region - Global Market Outlook t...
$ 3500